share_log
Moomoo 24/7 ·  Apr 12 11:31
Agenus Shares Are Trading Lower. The Company Announced Updated Results From Its Phase 1 Clinical Trial of BOT/BAL Combination Therapy in Patients With Metastatic CRC That Is Not Microsatellite Instability-high or Deficient Mismatch Repair
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment